Search research articles
Contact Us
Filters
Showing results (121-130 of 162) with videos related to
Page
of 17
Sort By:
Liver
|
December 5, 1997
The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C
S Shev, A P Dhillon, M Lindh, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology
|
February 1, 1982
IgM antibody to the hepatitis B core antigen in acute hepatitis determined by SPRIA--diagnostic value
A Widell, B G Hansson, B Löfgren, et al.
Scandinavian Journal of Infectious Diseases
|
August 14, 1999
Chronic hepatitis B in children in Gothenburg, Sweden
A Söderström, M Lindh, K Eriksson, et al.
Scandinavian Journal of Infectious Diseases
|
August 26, 2000
Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens
M Gisslén, B Svennerholm, G Norkrans, et al.
Scandinavian Journal of Infectious Diseases
|
October 31, 2000
Chronic hepatitis C--Swedish experts' meeting recommends combination treatment
R Wejstål, B Fischler, H Glaumann, et al.
AIDS Research and Human Retroviruses
|
June 1, 1992
Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals
A von Gegerfelt, F Chiodi, B Keys, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
February 25, 1998
Histamine and the response to IFN-alpha in chronic hepatitis C
K Hellstrand, M Brune, U H Mellqvist, et al.
Clinical and Experimental Immunology
|
March 1, 1992
Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment
R Wejstål, G Norkrans, O Weiland, et al.
Hematology (Amsterdam, Netherlands)
|
July 14, 2016
Activated Cellular Immunity in Chronic Hepatitis C
A Diez-Ruiz, G Norkrans, R Wejstal, et al.
Lakartidningen
|
December 10, 1999
[Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin]
R Wejstål, B Fischler, H Glaumann, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 162) with videos related to
Sort By:
Page
of 17
Liver
|
December 5, 1997
The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C
S Shev, A P Dhillon, M Lindh, et al.
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology
|
February 1, 1982
IgM antibody to the hepatitis B core antigen in acute hepatitis determined by SPRIA--diagnostic value
A Widell, B G Hansson, B Löfgren, et al.
Scandinavian Journal of Infectious Diseases
|
August 14, 1999
Chronic hepatitis B in children in Gothenburg, Sweden
A Söderström, M Lindh, K Eriksson, et al.
Scandinavian Journal of Infectious Diseases
|
August 26, 2000
Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens
M Gisslén, B Svennerholm, G Norkrans, et al.
Scandinavian Journal of Infectious Diseases
|
October 31, 2000
Chronic hepatitis C--Swedish experts' meeting recommends combination treatment
R Wejstål, B Fischler, H Glaumann, et al.
AIDS Research and Human Retroviruses
|
June 1, 1992
Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals
A von Gegerfelt, F Chiodi, B Keys, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
February 25, 1998
Histamine and the response to IFN-alpha in chronic hepatitis C
K Hellstrand, M Brune, U H Mellqvist, et al.
Clinical and Experimental Immunology
|
March 1, 1992
Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment
R Wejstål, G Norkrans, O Weiland, et al.
Hematology (Amsterdam, Netherlands)
|
July 14, 2016
Activated Cellular Immunity in Chronic Hepatitis C
A Diez-Ruiz, G Norkrans, R Wejstal, et al.
Lakartidningen
|
December 10, 1999
[Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin]
R Wejstål, B Fischler, H Glaumann, et al.
Page
of 17